Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-11
DOI
10.1038/s41598-020-61402-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toxicogenomic analysis identifies the apoptotic pathway as the main cause of hepatotoxicity induced by tributyltin
- (2016) Mi Zhou et al. FOOD AND CHEMICAL TOXICOLOGY
- Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
- (2016) Wantae Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
- (2016) Fei Meng et al. Frontiers in Genetics
- miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
- (2016) Cuiju Wang et al. Scientific Reports
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
- (2015) Kyung-Ju Choi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Investigation of the methylation of Numb by the SET8 protein lysine methyltransferase
- (2015) Sara Weirich et al. Scientific Reports
- MDM2-p53 Pathway in Hepatocellular Carcinoma
- (2014) X. Meng et al. CANCER RESEARCH
- SET8 methyltransferase activity during the DNA double-strand break response is required for recruitment of 53BP1
- (2014) S. Dulev et al. EMBO REPORTS
- Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
- (2014) Anqi Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression
- (2012) M. Takawa et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription
- (2012) D. B. Beck et al. GENES & DEVELOPMENT
- SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities
- (2011) Fen Yang et al. EMBO JOURNAL
- A polymorphism at the miR-502 binding site in the 3′-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome
- (2011) Zhanjun Guo et al. INTERNATIONAL JOURNAL OF CANCER
- The Histone Modifications GoverningTFF1Transcription Mediated by Estrogen Receptor
- (2011) Yanyan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation
- (2011) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRL4Cdt2 Regulates Cell Proliferation and Histone Gene Expression by Targeting PR-Set7/Set8 for Degradation
- (2010) Tarek Abbas et al. MOLECULAR CELL
- Reactome: a database of reactions, pathways and biological processes
- (2010) D. Croft et al. NUCLEIC ACIDS RESEARCH
- Antiproliferative and apoptotic effects of paeonol on human hepatocellular carcinoma cells
- (2009) Zhang Chunhu et al. ANTI-CANCER DRUGS
- A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse
- (2008) G. Schotta et al. GENES & DEVELOPMENT
- Direct Interaction between SET8 and Proliferating Cell Nuclear Antigen Couples H4-K20 Methylation with DNA Replication
- (2008) Michael S. Y. Huen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started